Figure S6. Palbociclib-mediated antagonism on bortezomib-induced cell death is not caused by alterations in cell cycle distribution. MCL cell line Mino was transfected with siRNA targeting RB1 and treated with 100 nM palbociclib 24 h post-transfection. After 16 h, cells were treated with 8 nM bortezomib. Twenty-four hours after treatment, cell cycle distribution was measured by BrdU staining (left), cell death was assessed by AnnexinV-PI staining (middle panel), and proteins were analyzed by Western blot (right). Data represent means ± S.D. from three independent experiments. (TIFF 802 kb
Figure S6. Combined treatment-induced cell death was not inhibited by the addition of autophagy inhi...
Figure S13. NOXA protein contains a potential LIR motif. The amino acid sequence DGFRRL at the posit...
Figure S7. Cell death was not regulated by the addition of SP600125 in ILz:rhTRAIL treated cells. (A...
Figure S8. Autophagy inhibitors counteract palbociclib-mediated antagonism on bortezomib-induced cel...
Figure S3. Double knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death similar ...
Figure S2. Knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death. MCL cell line ...
Figure S7. Palbociclib treatment induces autophagy but not after a short treatment period. (A) MCL c...
Figure S1. CDK4 inhibition by palbociclib treatment inhibits RB1 phosphorylation. MCL cell lines Jek...
Figure S9. Co-treatment of bortezomib with autophagy inhibitors potentiates cell death induction. MC...
Figure S5. Inhibition CDK4 activity hardly alters NOXA mRNA levels after proteasome inhibition. MCL ...
Figure S4. CDK4 inhibition antagonizes cell death of NOXA inducing substances. MCL cell line Jeko-1 ...
Figure S10. Synergistic cell death after proteasome inhibition and simultaneous fatty acid inhibitio...
Figure S11. Combination of proteasome inhibition and simultaneous fatty acid inhibition regulates ma...
Figure S12. Proteasome inhibitors combined with fatty acid inhibition induce synergistic cell death....
Table S1. Sequences targeted by the siRNAs used for gene silencing. (TIFF 883 kb
Figure S6. Combined treatment-induced cell death was not inhibited by the addition of autophagy inhi...
Figure S13. NOXA protein contains a potential LIR motif. The amino acid sequence DGFRRL at the posit...
Figure S7. Cell death was not regulated by the addition of SP600125 in ILz:rhTRAIL treated cells. (A...
Figure S8. Autophagy inhibitors counteract palbociclib-mediated antagonism on bortezomib-induced cel...
Figure S3. Double knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death similar ...
Figure S2. Knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death. MCL cell line ...
Figure S7. Palbociclib treatment induces autophagy but not after a short treatment period. (A) MCL c...
Figure S1. CDK4 inhibition by palbociclib treatment inhibits RB1 phosphorylation. MCL cell lines Jek...
Figure S9. Co-treatment of bortezomib with autophagy inhibitors potentiates cell death induction. MC...
Figure S5. Inhibition CDK4 activity hardly alters NOXA mRNA levels after proteasome inhibition. MCL ...
Figure S4. CDK4 inhibition antagonizes cell death of NOXA inducing substances. MCL cell line Jeko-1 ...
Figure S10. Synergistic cell death after proteasome inhibition and simultaneous fatty acid inhibitio...
Figure S11. Combination of proteasome inhibition and simultaneous fatty acid inhibition regulates ma...
Figure S12. Proteasome inhibitors combined with fatty acid inhibition induce synergistic cell death....
Table S1. Sequences targeted by the siRNAs used for gene silencing. (TIFF 883 kb
Figure S6. Combined treatment-induced cell death was not inhibited by the addition of autophagy inhi...
Figure S13. NOXA protein contains a potential LIR motif. The amino acid sequence DGFRRL at the posit...
Figure S7. Cell death was not regulated by the addition of SP600125 in ILz:rhTRAIL treated cells. (A...